Funding Life Science Innovations: A Venture Capital Perspective

Angelika Vlachou ()
Additional contact information
Angelika Vlachou: Venture Capital Professional Investor in Life Sciences

A chapter in Life Science Management, 2022, pp 13-28 from Springer

Abstract: Abstract Scientists, policymakers, and other stakeholders agree that venture capital is a very important element of the innovation pipeline in the life sciences industry (Karpa & Grginović, 2020; Ford & Nelsen, 2014)., However, securing funding at the very beginning of the life sciences innovation pathway is challenging and requires a deep understanding of the investment strategies used by venture capitalists. In turn, this requires a closer look at this type of financing and its investment criteria.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:mgmchp:978-3-030-98764-0_2

Ordering information: This item can be ordered from
http://www.springer.com/9783030987640

DOI: 10.1007/978-3-030-98764-0_2

Access Statistics for this chapter

More chapters in Management for Professionals from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().